John W. Higuchi is Director at Lipocine Inc. (LPCN). They have made 7 open-market trades across 1 company since 2015, most recently 2026-09-30.
CIK 0001579891
6 open-market purchases totalling $549K since 2015, against 1 sale. Across 6 scored buys the stock is up 3.8% at seven days, and 2.8 points ahead of the S&P over the same stretch.
6 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| LPCN | 241,365 | $384K |
Shares reported on the most recent Form 4, priced at the 2026-10-01 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 50% | — | — |
| Avg Move | +3.8% | — | — |
| Alpha | +2.8% | — | — |
| Scored | 6 | 4 | 4 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| LPCN | BUY | 2026-09-29 | 2026-10-01 | $2.20 | $55K | -22.7% | — | — |
| LPCN | BUY | 2026-09-28 | 2026-09-30 | $2.16 | $27K | -22.2% | — | — |
| LPCN | BUY | 2026-04-07 | 2026-04-07 | $2.03 | $81K | +15.7% | +14.3% | +17.4% |
| LPCN | BUY | 2026-04-06 | 2026-04-06 | $2.05 | $252K | +26.1% | +20.2% | +21.4% |
| LPCN | SELL | 2020-12-31 | 2021-01-04 | $1.35 | $9K | +14.6% | +22.9% | +9.7% |
| LPCN | BUY | 2020-03-17 | 2020-03-18 | $0.32 | $70K | +43.9% | +51.2% | +184.8% |
| LPCN | BUY | 2015-09-30 | 2015-10-02 | $12.68 | $63K | -17.9% | +0.0% | +0.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.